<billStatus>
 <version>
  3.0.0
 </version>
 <bill>
  <number>
   3927
  </number>
  <updateDate>
   2023-03-08T19:58:48Z
  </updateDate>
  <updateDateIncludingText>
   2023-03-08T19:58:48Z
  </updateDateIncludingText>
  <originChamber>
   House
  </originChamber>
  <type>
   HR
  </type>
  <introducedDate>
   2021-06-16
  </introducedDate>
  <congress>
   117
  </congress>
  <constitutionalAuthorityStatementText>
   &lt;pre&gt;[Congressional Record Volume 167, Number 105 (Wednesday, June 16, 2021)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. CARTER of Georgia:H.R. 3927.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8 of the U.S. Constitution[Page H2892]&lt;/pre&gt;
  </constitutionalAuthorityStatementText>
  <committees>
   <item>
    <systemCode>
     hsif00
    </systemCode>
    <name>
     Energy and Commerce Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <subcommittees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
      <activities>
       <item>
        <name>
         Referred to
        </name>
        <date>
         2021-06-17T21:35:53Z
        </date>
       </item>
      </activities>
     </item>
    </subcommittees>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-06-16T14:01:10Z
      </date>
     </item>
    </activities>
   </item>
   <item>
    <systemCode>
     hswm00
    </systemCode>
    <name>
     Ways and Means Committee
    </name>
    <chamber>
     House
    </chamber>
    <type>
     Standing
    </type>
    <activities>
     <item>
      <name>
       Referred to
      </name>
      <date>
       2021-06-16T14:01:15Z
      </date>
     </item>
    </activities>
   </item>
  </committees>
  <relatedBills>
   <item>
    <title>
     MADE in America Act
    </title>
    <congress>
     117
    </congress>
    <number>
     2082
    </number>
    <type>
     S
    </type>
    <latestAction>
     <actionDate>
      2021-06-16
     </actionDate>
     <text>
      Read twice and referred to the Committee on Finance.
     </text>
    </latestAction>
    <relationshipDetails>
     <item>
      <type>
       Identical bill
      </type>
      <identifiedBy>
       CRS
      </identifiedBy>
     </item>
    </relationshipDetails>
   </item>
  </relatedBills>
  <actions>
   <item>
    <actionDate>
     2021-06-17
    </actionDate>
    <committees>
     <item>
      <systemCode>
       hsif14
      </systemCode>
      <name>
       Health Subcommittee
      </name>
     </item>
    </committees>
    <sourceSystem>
     <code>
      1
     </code>
     <name>
      House committee actions
     </name>
    </sourceSystem>
    <text>
     Referred to the Subcommittee on Health.
    </text>
    <type>
     Committee
    </type>
   </item>
   <item>
    <actionDate>
     2021-06-16
    </actionDate>
    <text>
     Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hswm00
      </systemCode>
      <name>
       Ways and Means Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-06-16
    </actionDate>
    <text>
     Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     H11100
    </actionCode>
    <sourceSystem>
     <code>
      2
     </code>
     <name>
      House floor actions
     </name>
    </sourceSystem>
    <committees>
     <item>
      <systemCode>
       hsif00
      </systemCode>
      <name>
       Energy and Commerce Committee
      </name>
     </item>
    </committees>
   </item>
   <item>
    <actionDate>
     2021-06-16
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     Intro-H
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
   <item>
    <actionDate>
     2021-06-16
    </actionDate>
    <text>
     Introduced in House
    </text>
    <type>
     IntroReferral
    </type>
    <actionCode>
     1000
    </actionCode>
    <sourceSystem>
     <code>
      9
     </code>
     <name>
      Library of Congress
     </name>
    </sourceSystem>
   </item>
  </actions>
  <sponsors>
   <item>
    <bioguideId>
     C001103
    </bioguideId>
    <fullName>
     Rep. Carter, Earl L. "Buddy" [R-GA-1]
    </fullName>
    <firstName>
     Earl
    </firstName>
    <lastName>
     Carter
    </lastName>
    <party>
     R
    </party>
    <state>
     GA
    </state>
    <middleName>
     L. "Buddy"
    </middleName>
    <district>
     1
    </district>
    <isByRequest>
     N
    </isByRequest>
   </item>
  </sponsors>
  <cosponsors>
   <item>
    <bioguideId>
     R000597
    </bioguideId>
    <fullName>
     Rep. Rice, Tom [R-SC-7]
    </fullName>
    <firstName>
     Tom
    </firstName>
    <lastName>
     Rice
    </lastName>
    <party>
     R
    </party>
    <state>
     SC
    </state>
    <district>
     7
    </district>
    <sponsorshipDate>
     2021-06-16
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     S001200
    </bioguideId>
    <fullName>
     Rep. Soto, Darren [D-FL-9]
    </fullName>
    <firstName>
     Darren
    </firstName>
    <lastName>
     Soto
    </lastName>
    <party>
     D
    </party>
    <state>
     FL
    </state>
    <district>
     9
    </district>
    <sponsorshipDate>
     2021-06-16
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     C001090
    </bioguideId>
    <fullName>
     Rep. Cartwright, Matt [D-PA-8]
    </fullName>
    <firstName>
     Matt
    </firstName>
    <lastName>
     Cartwright
    </lastName>
    <party>
     D
    </party>
    <state>
     PA
    </state>
    <district>
     8
    </district>
    <sponsorshipDate>
     2021-06-16
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     V000133
    </bioguideId>
    <fullName>
     Rep. Van Drew, Jefferson [R-NJ-2]
    </fullName>
    <firstName>
     Jefferson
    </firstName>
    <lastName>
     Van Drew
    </lastName>
    <party>
     R
    </party>
    <state>
     NJ
    </state>
    <district>
     2
    </district>
    <sponsorshipDate>
     2021-06-16
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     W000821
    </bioguideId>
    <fullName>
     Rep. Westerman, Bruce [R-AR-4]
    </fullName>
    <firstName>
     Bruce
    </firstName>
    <lastName>
     Westerman
    </lastName>
    <party>
     R
    </party>
    <state>
     AR
    </state>
    <district>
     4
    </district>
    <sponsorshipDate>
     2021-06-16
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     C001087
    </bioguideId>
    <fullName>
     Rep. Crawford, Eric A. "Rick" [R-AR-1]
    </fullName>
    <firstName>
     Eric
    </firstName>
    <lastName>
     Crawford
    </lastName>
    <party>
     R
    </party>
    <state>
     AR
    </state>
    <middleName>
     A. "Rick"
    </middleName>
    <district>
     1
    </district>
    <sponsorshipDate>
     2021-06-16
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     M001180
    </bioguideId>
    <fullName>
     Rep. McKinley, David B. [R-WV-1]
    </fullName>
    <firstName>
     David
    </firstName>
    <lastName>
     McKinley
    </lastName>
    <party>
     R
    </party>
    <state>
     WV
    </state>
    <middleName>
     B.
    </middleName>
    <district>
     1
    </district>
    <sponsorshipDate>
     2021-06-16
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     G000568
    </bioguideId>
    <fullName>
     Rep. Griffith, H. Morgan [R-VA-9]
    </fullName>
    <firstName>
     H.
    </firstName>
    <lastName>
     Griffith
    </lastName>
    <party>
     R
    </party>
    <state>
     VA
    </state>
    <middleName>
     Morgan
    </middleName>
    <district>
     9
    </district>
    <sponsorshipDate>
     2021-06-16
    </sponsorshipDate>
    <isOriginalCosponsor>
     True
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     K000386
    </bioguideId>
    <fullName>
     Rep. Katko, John [R-NY-24]
    </fullName>
    <firstName>
     John
    </firstName>
    <lastName>
     Katko
    </lastName>
    <party>
     R
    </party>
    <state>
     NY
    </state>
    <district>
     24
    </district>
    <sponsorshipDate>
     2021-12-02
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     B001306
    </bioguideId>
    <fullName>
     Rep. Balderson, Troy [R-OH-12]
    </fullName>
    <firstName>
     Troy
    </firstName>
    <lastName>
     Balderson
    </lastName>
    <party>
     R
    </party>
    <state>
     OH
    </state>
    <district>
     12
    </district>
    <sponsorshipDate>
     2021-12-02
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     H001067
    </bioguideId>
    <fullName>
     Rep. Hudson, Richard [R-NC-8]
    </fullName>
    <firstName>
     Richard
    </firstName>
    <lastName>
     Hudson
    </lastName>
    <party>
     R
    </party>
    <state>
     NC
    </state>
    <district>
     8
    </district>
    <sponsorshipDate>
     2022-03-15
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     J000304
    </bioguideId>
    <fullName>
     Rep. Jackson, Ronny [R-TX-13]
    </fullName>
    <firstName>
     Ronny
    </firstName>
    <lastName>
     Jackson
    </lastName>
    <party>
     R
    </party>
    <state>
     TX
    </state>
    <district>
     13
    </district>
    <sponsorshipDate>
     2022-03-15
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     M001190
    </bioguideId>
    <fullName>
     Rep. Mullin, Markwayne [R-OK-2]
    </fullName>
    <firstName>
     Markwayne
    </firstName>
    <lastName>
     Mullin
    </lastName>
    <party>
     R
    </party>
    <state>
     OK
    </state>
    <district>
     2
    </district>
    <sponsorshipDate>
     2022-03-24
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
   <item>
    <bioguideId>
     D000628
    </bioguideId>
    <fullName>
     Rep. Dunn, Neal P. [R-FL-2]
    </fullName>
    <firstName>
     Neal
    </firstName>
    <lastName>
     Dunn
    </lastName>
    <party>
     R
    </party>
    <state>
     FL
    </state>
    <middleName>
     P.
    </middleName>
    <district>
     2
    </district>
    <sponsorshipDate>
     2022-05-10
    </sponsorshipDate>
    <isOriginalCosponsor>
     False
    </isOriginalCosponsor>
   </item>
  </cosponsors>
  <policyArea>
   <name>
    Health
   </name>
  </policyArea>
  <subjects>
   <legislativeSubjects/>
   <policyArea>
    <name>
     Health
    </name>
   </policyArea>
  </subjects>
  <summaries>
   <summary>
    <versionCode>
     00
    </versionCode>
    <actionDate>
     2021-06-16
    </actionDate>
    <actionDesc>
     Introduced in House
    </actionDesc>
    <updateDate>
     2022-07-14T16:30:44Z
    </updateDate>
    <text>
     &lt;p&gt;&lt;strong&gt;Manufacturing API, Drugs, and Excipients in America Act or the MADE in America Act&lt;/strong&gt;&lt;/p&gt; &lt;p&gt;This bill establishes a tax credit for taxpayers engaged in medical production activities in certain areas and contains other provisions related to pharmaceuticals.&lt;/p&gt; &lt;p&gt;An eligible taxpayer may claim a tax credit equal to 25% of qualified expenditures related to the production of pharmaceuticals, medical devices, or other related items in a designated qualified opportunity zone with a poverty rate higher than 30%. The bill provides for increases to this tax credit in certain situations, such as if a substantial portion of the employees reside in areas with certain poverty levels. &lt;/p&gt; &lt;p&gt;In addition, the Food and Drug Administration (FDA) must continue programs to facilitate the development and review of new drug or biological products that are manufactured using certain advanced manufacturing technologies. The bill imposes various requirements on these programs, including deadlines for evaluating such a technology. &lt;/p&gt; &lt;p&gt;Furthermore, the Department of Health and Human Services must ensure timely and effective internal coordination and alignment between FDA field investigators and the staff of the Center for Drug Evaluation and Research's Office of Compliance and Drug Shortage Program regarding reports and feedback related to facility inspections. &lt;/p&gt;
    </text>
   </summary>
  </summaries>
  <title>
   MADE in America Act
  </title>
  <titles>
   <item>
    <titleType>
     Display Title
    </titleType>
    <title>
     MADE in America Act
    </title>
   </item>
   <item>
    <titleType>
     Official Title as Introduced
    </titleType>
    <title>
     To mitigate drug shortages and provide incentives for maintaining, expanding, and relocating the manufacturing of active pharmaceutical ingredients, excipients, medical diagnostic devices, pharmaceuticals, and personal protective equipment in the United States, and for other purposes.
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     MADE in America Act
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
   <item>
    <titleType>
     Short Title(s) as Introduced
    </titleType>
    <title>
     Manufacturing API, Drugs, and Excipients in America Act
    </title>
    <billTextVersionName>
     Introduced in House
    </billTextVersionName>
    <billTextVersionCode>
     IH
    </billTextVersionCode>
   </item>
  </titles>
  <textVersions>
   <item>
    <type>
     Introduced in House
    </type>
    <date>
     2021-06-16T04:00:00Z
    </date>
    <formats>
     <item>
      <url>
       https://www.govinfo.gov/content/pkg/BILLS-117hr3927ih/xml/BILLS-117hr3927ih.xml
      </url>
     </item>
    </formats>
   </item>
  </textVersions>
  <latestAction>
   <actionDate>
    2021-06-17
   </actionDate>
   <text>
    Referred to the Subcommittee on Health.
   </text>
  </latestAction>
 </bill>
 <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
  <dc:format>
   text/xml
  </dc:format>
  <dc:language>
   EN
  </dc:language>
  <dc:rights>
   Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
  </dc:rights>
  <dc:contributor>
   Congressional Research Service, Library of Congress
  </dc:contributor>
  <dc:description>
   This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
  </dc:description>
 </dublinCore>
</billStatus>

2021-06-17
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-06-16
Ways and Means Committee
hswm00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-06-16
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
Intro-H
2021-06-16
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-06-16
9
Library of Congress
Introduced in House
IntroReferral
2021-06-16T14:01:10Z
Referred to
House
Energy and Commerce Committee
2021-06-17T21:35:53Z
Referred to
Health Subcommittee
hsif14
hsif00
Standing
2021-06-16T14:01:15Z
Referred to
House
Ways and Means Committee
hswm00
Standing
R000597
7
Tom
Rep. Rice, Tom [R-SC-7]
Rice
R
2021-06-16
SC
S001200
9
Darren
Rep. Soto, Darren [D-FL-9]
Soto
D
2021-06-16
FL
C001090
8
Matt
Rep. Cartwright, Matt [D-PA-8]
Cartwright
D
2021-06-16
PA
V000133
2
Jefferson
Rep. Van Drew, Jefferson [R-NJ-2]
Van Drew
R
2021-06-16
NJ
W000821
4
Bruce
Rep. Westerman, Bruce [R-AR-4]
Westerman
R
2021-06-16
AR
C001087
1
Eric
Rep. Crawford, Eric A. "Rick" [R-AR-1]
Crawford
A. "Rick"
R
2021-06-16
AR
M001180
1
David
Rep. McKinley, David B. [R-WV-1]
McKinley
B.
R
2021-06-16
WV
G000568
9
H.
Rep. Griffith, H. Morgan [R-VA-9]
Griffith
Morgan
R
2021-06-16
VA
K000386
24
John
Rep. Katko, John [R-NY-24]
Katko
R
2021-12-02
NY
B001306
12
Troy
Rep. Balderson, Troy [R-OH-12]
Balderson
R
2021-12-02
OH
H001067
8
Richard
Rep. Hudson, Richard [R-NC-8]
Hudson
R
2022-03-15
NC
J000304
13
Ronny
Rep. Jackson, Ronny [R-TX-13]
Jackson
R
2022-03-15
TX
M001190
2
Markwayne
Rep. Mullin, Markwayne [R-OK-2]
Mullin
R
2022-03-24
OK
D000628
2
Neal
Rep. Dunn, Neal P. [R-FL-2]
Dunn
P.
R
2022-05-10
FL
Congressional Research Service, Library of Congress
This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
2021-06-16
2021-06-17
Referred to the Subcommittee on Health.
House
Health
2021-06-16
Read twice and referred to the Committee on Finance.
CRS
Identical bill
MADE in America Act
S
C001103
1
Earl
Rep. Carter, Earl L. "Buddy" [R-GA-1]
N
Carter
L. "Buddy"
R
GA
2021-06-16
Introduced in House
 <p><strong>Manufacturing API, Drugs, and Excipients in America Act or the MADE in America Act</strong></p> <p>This bill establishes a tax credit for taxpayers engaged in medical production activities in certain areas and contains other provisions related to pharmaceuticals.</p> <p>An eligible taxpayer may claim a tax credit equal to 25% of qualified expenditures related to the production of pharmaceuticals, medical devices, or other related items in a designated qualified opportunity zone with a poverty rate higher than 30%. The bill provides for increases to this tax credit in certain situations, such as if a substantial portion of the employees reside in areas with certain poverty levels. </p> <p>In addition, the Food and Drug Administration (FDA) must continue programs to facilitate the development and review of new drug or biological products that are manufactured using certain advanced manufacturing technologies. The bill imposes various requirements on these programs, including deadlines for evaluating such a technology. </p> <p>Furthermore, the Department of Health and Human Services must ensure timely and effective internal coordination and alignment between FDA field investigators and the staff of the Center for Drug Evaluation and Research's Office of Compliance and Drug Shortage Program regarding reports and feedback related to facility inspections. </p>
2022-07-14T16:30:44Z
00
2021-06-16T04:00:00Z
Introduced in House
https://www.govinfo.gov/content/pkg/BILLS-117hr3927ih/xml/BILLS-117hr3927ih.xml
MADE in America Act
MADE in America Act
Display Title
IH
Introduced in House
To mitigate drug shortages and provide incentives for maintaining, expanding, and relocating the manufacturing of active pharmaceutical ingredients, excipients, medical diagnostic devices, pharmaceuticals, and personal protective equipment in the United States, and for other purposes.
Official Title as Introduced
IH
Introduced in House
MADE in America Act
Short Title(s) as Introduced
IH
Introduced in House
Manufacturing API, Drugs, and Excipients in America Act
Short Title(s) as Introduced
HR
2023-03-08T19:58:48Z
2023-03-08T19:58:48Z
3.0.0
2021-06-16
Read twice and referred to the Committee on Finance.
CRS
Identical bill
MADE in America Act
S
2021-06-17
Health Subcommittee
hsif14
1
House committee actions
Referred to the Subcommittee on Health.
Committee
H11100
2021-06-16
Ways and Means Committee
hswm00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
H11100
2021-06-16
Energy and Commerce Committee
hsif00
2
House floor actions
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
IntroReferral
Intro-H
2021-06-16
9
Library of Congress
Introduced in House
IntroReferral
1000
2021-06-16
9
Library of Congress
Introduced in House
IntroReferral
C001103
1
Earl
Rep. Carter, Earl L. "Buddy" [R-GA-1]
N
Carter
L. "Buddy"
R
GA
R000597
7
Tom
Rep. Rice, Tom [R-SC-7]
Rice
R
2021-06-16
SC
S001200
9
Darren
Rep. Soto, Darren [D-FL-9]
Soto
D
2021-06-16
FL
C001090
8
Matt
Rep. Cartwright, Matt [D-PA-8]
Cartwright
D
2021-06-16
PA
V000133
2
Jefferson
Rep. Van Drew, Jefferson [R-NJ-2]
Van Drew
R
2021-06-16
NJ
W000821
4
Bruce
Rep. Westerman, Bruce [R-AR-4]
Westerman
R
2021-06-16
AR
C001087
1
Eric
Rep. Crawford, Eric A. "Rick" [R-AR-1]
Crawford
A. "Rick"
R
2021-06-16
AR
M001180
1
David
Rep. McKinley, David B. [R-WV-1]
McKinley
B.
R
2021-06-16
WV
G000568
9
H.
Rep. Griffith, H. Morgan [R-VA-9]
Griffith
Morgan
R
2021-06-16
VA
K000386
24
John
Rep. Katko, John [R-NY-24]
Katko
R
2021-12-02
NY
B001306
12
Troy
Rep. Balderson, Troy [R-OH-12]
Balderson
R
2021-12-02
OH
H001067
8
Richard
Rep. Hudson, Richard [R-NC-8]
Hudson
R
2022-03-15
NC
J000304
13
Ronny
Rep. Jackson, Ronny [R-TX-13]
Jackson
R
2022-03-15
TX
M001190
2
Markwayne
Rep. Mullin, Markwayne [R-OK-2]
Mullin
R
2022-03-24
OK
D000628
2
Neal
Rep. Dunn, Neal P. [R-FL-2]
Dunn
P.
R
2022-05-10
FL
2021-06-16
Introduced in House
 <p><strong>Manufacturing API, Drugs, and Excipients in America Act or the MADE in America Act</strong></p> <p>This bill establishes a tax credit for taxpayers engaged in medical production activities in certain areas and contains other provisions related to pharmaceuticals.</p> <p>An eligible taxpayer may claim a tax credit equal to 25% of qualified expenditures related to the production of pharmaceuticals, medical devices, or other related items in a designated qualified opportunity zone with a poverty rate higher than 30%. The bill provides for increases to this tax credit in certain situations, such as if a substantial portion of the employees reside in areas with certain poverty levels. </p> <p>In addition, the Food and Drug Administration (FDA) must continue programs to facilitate the development and review of new drug or biological products that are manufactured using certain advanced manufacturing technologies. The bill imposes various requirements on these programs, including deadlines for evaluating such a technology. </p> <p>Furthermore, the Department of Health and Human Services must ensure timely and effective internal coordination and alignment between FDA field investigators and the staff of the Center for Drug Evaluation and Research's Office of Compliance and Drug Shortage Program regarding reports and feedback related to facility inspections. </p>
2022-07-14T16:30:44Z
00
MADE in America Act
MADE in America Act
Display Title
IH
Introduced in House
To mitigate drug shortages and provide incentives for maintaining, expanding, and relocating the manufacturing of active pharmaceutical ingredients, excipients, medical diagnostic devices, pharmaceuticals, and personal protective equipment in the United States, and for other purposes.
Official Title as Introduced
IH
Introduced in House
MADE in America Act
Short Title(s) as Introduced
IH
Introduced in House
Manufacturing API, Drugs, and Excipients in America Act
Short Title(s) as Introduced
2021-06-17
Referred to the Subcommittee on Health.